Credit Suisse initiated coverage on Amgen (NASDAQ: AMGN) with an Underperform rating and a price target of $240.00. The analysts ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE